VNN1 and neoplasm: Treatment with Vnn1 pantetheinase, which degrades pantetheine into pantothenate and cysteamine, led to increased mitochondrial CoA levels and a move from glycolysis to oxidative phosphorylation, thereby suppressing tumor growth (Figure 5) [162].